Device–device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices
Heart Rhythm · 2023
DOI: 10.1016/j.hrthm.2023.02.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart Rhythm, 2023. Verfasst von Tanyanan Tanawuttiwat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Indiana University, Indianapolis, Indiana. Electronic address: ttanawu@iu.edu. Hauptthemen laut MEDLINE: Heart-Assist Devices, Pacemaker, Artificial, Defibrillators, Implantable, Cardiac Resynchronization Therapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Medtronic, Boston Scientific Corporation.
Abstract (Originalsprache)
The current design of an innovative left ventricular assist device (LVAD) makes use of magnetic levitation technology, which enables the rotors of the device to be completely suspended by magnetic force, reducing friction and blood or plasma damage. However, this electromagnetic field can result in electromagnetic interference (EMI), which can interfere with proper functioning of another cardiac implantable electronic device (CIED) in its direct proximity. Approximately 80% of patients with an LVAD have a CIED, most frequently an implantable cardioverter-defibrillator (ICD). Several device-device interactions have been reported, including EMI-induced inappropriate shocks, inability to establish telemetry connection, EMI-induced premature battery depletion, undersensing by the device, and other CIED malfunctions. Unfortunately, additional procedures, including generator exchange, lead adjustment, and system extraction, are frequently required because of these interactions. In some circumstances, the additional procedure might be preventable or avoidable with appropriate solutions. In this article, we describe how EMI from the LVAD impacts the functionality of the CIED and provide possible management options, including manufacturer-specific information, for the current CIEDs (eg, transvenous and leadless pacemakers, transvenous and subcutaneous ICDs, and transvenous cardiac resynchronization therapy pacemakers and ICDs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Indiana University, Indianapolis, Indiana. Electronic address: ttanawu@iu.edu.
- Division of Cardiovascular Medicine, Indiana University, Indianapolis, Indiana.
Förderung
- Medtronic
- Boston Scientific Corporation
Zitieren
APA
Tanawuttiwat, T., Das, M. K., Miller, J. M., & Guglin, M. E. (2023). Device–device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2023.02.020
Vancouver
Tanawuttiwat T, Das MK, Miller JM, Guglin ME. Device–device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices. Heart Rhythm. 2023. doi:10.1016/j.hrthm.2023.02.020
BibTeX
@article{Tanawuttiwat2023,
author = {Tanawuttiwat, Tanyanan and Das, Mithilesh K and Miller, John M and Guglin, Maya E},
title = {Device–device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices},
journal = {Heart Rhythm},
year = {2023},
doi = {10.1016/j.hrthm.2023.02.020}
}
EUVIMED